 Parsippany, NJ, April 12, 2021 GLOBE NEWSWIRE -- Interpace Pharma Solutions, a subsidiary of Interpace Biosciences, Inc. Interpace or the Company OTCQX: IDXG announced today new capability in advancing RNA biomarker analysis for gene and cell-based therapies. 